Tumor-Targeted Erythrocyte Membrane Nanoparticles for Theranostics of Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) cells do not contain various receptors for targeted treatment, a reason behind the poor prognosis of this disease. In this study, biocompatible theranostic erythrocyte-derived nanoparticles (EDNs) were developed and evaluated for effective early diagnosis and tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Moon Jung, Lee, Yeon Kyung, Choi, Kang Chan, Lee, Do Hyun, Jeong, Hwa Yeon, Kang, Seong Jae, Kim, Min Woo, You, Young Myoung, Im, Chan Su, Lee, Tae Sup, Park, Yong Serk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966336/
https://www.ncbi.nlm.nih.gov/pubmed/36839675
http://dx.doi.org/10.3390/pharmaceutics15020350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966336/
https://www.ncbi.nlm.nih.gov/pubmed/36839675
http://dx.doi.org/10.3390/pharmaceutics15020350

Ejemplares similares